New hope for advanced cancers: combo therapy trial launches
NCT ID NCT06953089
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tests two new drug combinations (DB-1311 with BNT327 or DB-1305) in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if these combinations are safe and can shrink tumors. About 492 participants will take part in this Phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AUS04-0
RECRUITINGBirtinya, Queensland, 4575, Australia
-
AUS05-0
RECRUITINGAdelaide, South Australia, 5000, Australia
-
AUS06-0
RECRUITINGBenowa, Queensland, 4217, Australia
-
AUS07-0
RECRUITINGNorth Sydney, New South Wales, 2060, Australia
-
CHN01-0
RECRUITINGShanghai, Shanghai Municipality, 200120, China
-
CHN02-0
RECRUITINGBeijing, Beijing Municipality, 100021, China
-
CHN04-0
RECRUITINGHubei, Hubei, 430014, China
-
CHN04-0
RECRUITINGShanghai, Shanghai Municipality, 200032, China
-
CHN06-0
RECRUITINGHenan, Henan, 450008, China
-
CHN11-0
RECRUITINGChangsha, Hunan, 410013, China
-
CHN12-0
RECRUITINGXinxiang, Henan, 453100, China
-
CHN13-0
RECRUITINGBeijing, Beijing Municipality, 100032, China
-
CHN16-0
RECRUITINGXuzhou, Jiangsu, 221000, China
-
CHN17-0
RECRUITINGDongguan, Guangdong, 523000, China
-
CHN23-0
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
CHN24-0
RECRUITINGChengdu, Sichuan, 610041, China
-
CHN25-0
RECRUITINGXi'an, Shaanxi, 710061, China
-
CHN26-0
RECRUITINGWuhan, Hubei, 00000, China
-
CHN34-0
RECRUITINGWuhan, Hubei, 430079, China
-
CHN35-0
RECRUITINGShenyang, Liaoning, 110042, China
-
TWN01-0
RECRUITINGTaipei, Taipei, 0, Taiwan
-
TWN02-0
RECRUITINGTaipei, Taipei, 23561, Taiwan
-
USA01-0
RECRUITINGWheat Ridge, Colorado, 80033, United States
-
USA03-0
RECRUITINGCharleston, South Carolina, 29425, United States
-
USA04-0
RECRUITINGNew York, New York, 10032, United States
-
USA05-0
RECRUITINGVirginia Beach, Virginia, 22031, United States
-
USA06-0
RECRUITINGLos Angeles, California, 90025, United States
-
USA07-0
RECRUITINGSpokane, Washington, 99208, United States
-
USA08-0
RECRUITINGFlorida City, Florida, 99208, United States
-
USA09-0
RECRUITINGPuyallup, Washington, 98373, United States
-
USA10-0
RECRUITINGAtlanta, Georgia, 30318, United States
-
USA11-0
RECRUITINGBethesda, Maryland, 20817, United States
-
USA12-0
RECRUITINGHouston, Texas, 77030, United States
-
USA13-0
RECRUITINGAnderson, Texas, 46011, United States
-
USA14-0
RECRUITINGLincoln, Nebraska, 68506, United States
-
USA15-0
RECRUITINGPortland, Oregon, 97239, United States
-
USA16-0
RECRUITINGLos Angeles, California, 90025, United States
Conditions
Explore the condition pages connected to this study.